Care Exim

About Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml

Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml is an antidiabetic medicine used to treat diabetes. It is used for the treatment of Type II Diabetes. Type II Diabetes Mellitus is a serious condition wherein the body doesn’t use insulin effectively, which causes unusual blood glucose levels. Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml is also used in combination with other medicines to treat obesity.

Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml contains Tirzepatide, which belongs to the class of GLP-1 receptor agonist. This medicine works by activating both GIP (glucose-dependent insulin polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors, thereby helping control blood sugar levels. It also helps reduce appetite by delaying the stomach's emptying process and interacting with brain areas that contain GLP-1 receptors, which signal feelings of fullness.

Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml should be administered as recommended by your doctor. Your doctor will clearly explain how to adjust the dose and administer the medicine. This medicine may cause specific side effects such as vomiting, nausea, abdominal pain, diarrhea, headache, and allergic reactions. If these side effects persist or worsen, please consult your doctor.

Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml should be avoided if you are allergic to any of the medicines or their components. Inform your doctor about your medical history and other conditions like liver/kidney disease, stomach problems, vision problems (retinopathy), pancreatitis, depression, and hypoglycemia. This can help prevent unwanted effects. Let your doctor know if you are pregnant or breastfeeding before taking Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml. This medicine should be stored in cold places at 2°C to 8°C.

Uses of Mounjaro Kwikpen 7.5 mg PFP Injection 0.6 ml

Ivermectin is an anti-parasite medication used to treat parasitic diseases, including parasitic worms, hookworm, whipworm, and external parasites. Ivermectin tablets (Stromectol) are FDA-approved to treat strongyloidiasis of the intestinal tract and onchocerciasis (river blindness). Ivermectin cream (Soolantra) is FDA-approved to treat rosacea, and ivermectin lotion (Sklice) is a treatment for head lice.
Ivermectin tablets have also been used off-label for scabies and other parasites.
Ivermectin works by paralyzing muscles in parasites, causing them to die. Ivermectin mechanism of action in parasites is by binding to glutamate-gated chloride channels (GluCl), causing paralysis. It does not affect mammals as it is unable to enter the mammal's central nervous system, where the GluCl channels are located. Ivermectin tablets are also thought to help the human immune response to being able to overcome immature worms and kill them. It is thought that ivermectin tablets may suppress the ability of the parasite to secrete proteins that help it to evade the host’s natural immune defence mechanism.

• Treatment of Bacterial infections